Given that the APPL2-RAF1 fusion was also detected using RT-PCR from the primary and recurrent tumor tissue in the mandible, it is reasonable to assume that it was the oncogenic driver since the initial tumor development. The gene discussed is RAF1; the disease is neoplasm.